SCHEMBL26014238

SCHEMBL26014238

Cc1ccccc1-c1cc([Si](C)(C)C)c(C)c[n+]1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.38
RAB9A P51151 8/20 0.38
SMN1; SMN2 Q16637 6/20 0.38
CASP3 P42574 2/20 0.38
SENP8 Q96LD8 2/20 0.38
SENP7 Q9BQF6 2/20 0.38
SENP6 Q9GZR1 2/20 0.38
ALDH1A1 P00352 5/20 0.33
HPGD P15428 4/20 0.33
PLA2G7 Q13093 2/20 0.33
TSHR P16473 2/20 0.33
MAPT P10636 3/20 0.33
CYP1A2 P05177 3/20 0.33
CYP2D6 P10635 3/20 0.33
CYP2C19 P33261 3/20 0.33
MEN1 O00255 2/20 0.33
CYP3A4 P08684 2/20 0.33
KMT2A Q03164 2/20 0.33
CYP2C9 P11712 1/20 0.33
NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26013109 0.87 NPC1 (0.38) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL26023574 0.86 NPC1 (0.37) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL26014286 0.83 NPC1 (0.33) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL26014242 0.83 F2 (0.34) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL26014243 0.83 NPC1 (0.33) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL26023575 0.83 NPC1 (0.37) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL26014555 0.82 NPC1 (0.33) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL26014524 0.82 ALDH1A1 (0.33) RAB9ASMN1; SMN2CASP3SENP8SENP7
SCHEMBL25445552 0.80 RAB9A (0.35) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL26013111 0.80 NPC1 (0.33) NPC1RAB9ASMN1; SMN2CASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713333-B2 Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713333-B2 Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound ORC3, LAGE3, ORMDL3 NPC1 2512/4885RAB9A 3590/4885SMN1; SMN2 4036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.